| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/02/2010 | US20100222324 Substituted Indole Compounds |
| 09/02/2010 | US20100222323 Imidazopyrazine syk inhibitors |
| 09/02/2010 | US20100222322 Non-Nucleoside Reverse Transcriptase Inhibitors |
| 09/02/2010 | US20100222321 Inhibitors of akt activtiy |
| 09/02/2010 | US20100222320 Triazole derivatives for treating alzheimer's disease and related conditions |
| 09/02/2010 | US20100222319 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 09/02/2010 | US20100222318 Compounds useful as inhibitors of atr kinase |
| 09/02/2010 | US20100222317 Azetidine Derivatives as GlyT1 Inhibitors |
| 09/02/2010 | US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 09/02/2010 | US20100222315 Patient populations and treatment methods |
| 09/02/2010 | US20100222314 Aqueous-based Pharmaceutical Composition |
| 09/02/2010 | US20100222313 Pharmaceutical compositions-4 |
| 09/02/2010 | US20100222312 Delayed-release glucocorticoid treatment of asthma |
| 09/02/2010 | US20100222311 Solid formulations of crystalline compounds |
| 09/02/2010 | US20100222310 Benzodiazepine compositions for treating epidermal hyperplasia and related disorders |
| 09/02/2010 | US20100222309 Skin property-improving therapeutic agent comprising a morphinan derivative or any of its pharmacologically permissible acid addition salts as an active ingredient |
| 09/02/2010 | US20100222308 Ophthalmic, otic or nasal pharmaceutical composition and the use thereof |
| 09/02/2010 | US20100222307 Vitamin d and vitamin d analogs or derivatives as new anti-hypertensive agents |
| 09/02/2010 | US20100222306 Class of Gamma Delta T Cells Activators and Use Thereof |
| 09/02/2010 | US20100222305 Complexes of phosphate derivatives |
| 09/02/2010 | US20100222304 Methods of Treating Neuropathic Pain by Modulation of Glycogenolysis or Glycolysis |
| 09/02/2010 | US20100222303 Reverse-turn mimetics and method relating thereto |
| 09/02/2010 | US20100222302 Novel Antibacterial Compounds |
| 09/02/2010 | US20100222301 Topical drug for treatment and/or prevention of diabetic neuropathy, microangiopathy and diabetic and non diabetic ulcers and wound infection |
| 09/02/2010 | US20100222300 A2B Adenosine Receptor Antagonists |
| 09/02/2010 | US20100222299 Compound |
| 09/02/2010 | US20100222298 Spill resistant formulations containing clays |
| 09/02/2010 | US20100222297 Cell wall derivatives, their preparation process, and use thereof |
| 09/02/2010 | US20100222296 Pyrimidines, such as uridine, in treatments for patients with bipolar disorder |
| 09/02/2010 | US20100222295 Anti-Viral Pyrimidine Nucleoside Derivatives |
| 09/02/2010 | US20100222294 Formulations of ATP and Analogs of ATP |
| 09/02/2010 | US20100222293 Modulation of sperm motility |
| 09/02/2010 | US20100222292 Method for transdifferentiation of body tissues |
| 09/02/2010 | US20100222291 Medicinal forms of phospholipid preparations and methods for their preparation |
| 09/02/2010 | US20100222290 Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics |
| 09/02/2010 | US20100222289 Methods for diagnosis and treatment of chronic fatigue syndrome |
| 09/02/2010 | US20100222287 Therapeutic Cancer Treatments |
| 09/02/2010 | US20100222286 Receptor modulators exhibiting neuroprotective and memory enhancing activities |
| 09/02/2010 | US20100222285 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation |
| 09/02/2010 | US20100222284 Composition for inhibiting the onset of arteriosclerosis and inhibition method |
| 09/02/2010 | US20100222283 Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal desease |
| 09/02/2010 | US20100222282 Method of diagnosis and method of treatment |
| 09/02/2010 | US20100222275 Therapeutic agent for vitiligo and method of accelerating pigmentation |
| 09/02/2010 | US20100222274 Glycosylation-deficient hepatocyte growth factor |
| 09/02/2010 | US20100222270 Heterocyclic compounds as crth2 receptor antagonists |
| 09/02/2010 | US20100222263 Atap peptides, nucleic acids encoding the same and associated methods of use |
| 09/02/2010 | US20100222262 Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions |
| 09/02/2010 | US20100222257 Substituted phenethylamines |
| 09/02/2010 | US20100222220 Compositions of particulate coformulation |
| 09/02/2010 | US20100222217 Fungicidal N-[2-(Haloalkoxy)Phenyl]Heteroarylcarboxamides |
| 09/02/2010 | US20100221840 Methods for testing for and inhibiting the development of huntington's disease |
| 09/02/2010 | US20100221766 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME |
| 09/02/2010 | US20100221746 Compositions and methods for the treatment of disease |
| 09/02/2010 | US20100221743 Methods for Diagnosing and Treating Endoplasmic Reticulum (ER) Stress Diseases |
| 09/02/2010 | US20100221731 Methods for assessing MetAP2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer |
| 09/02/2010 | US20100221730 Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer |
| 09/02/2010 | US20100221729 Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer |
| 09/02/2010 | US20100221445 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
| 09/02/2010 | US20100221372 Wolfberries and skin inflammation |
| 09/02/2010 | US20100221358 Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders |
| 09/02/2010 | US20100221357 Drug delivery product and methods |
| 09/02/2010 | US20100221356 Pharmaceutical composition for once a day administration of trospium chloride |
| 09/02/2010 | US20100221355 Pharmaceutical composition for once-a-day oral administration of trospium chloride |
| 09/02/2010 | US20100221354 Pharmaceutical composition for once-a-day oral administration of trospium chloride |
| 09/02/2010 | US20100221353 Pharmaceutical Composition For Once-A-Day Administration of Trospium Chloride |
| 09/02/2010 | US20100221352 Pharmaceutical composition for the once-a-day oral administration of trospium chloride |
| 09/02/2010 | US20100221351 Controlled Drug Delivery Using a Thermally Responsive Nanocapsule to Augment Cryoablation |
| 09/02/2010 | US20100221350 Dermatological compositions comprising vitamin d lipid vesicles |
| 09/02/2010 | US20100221349 Nucleic acid constructs |
| 09/02/2010 | US20100221348 Therapeutic uses of dunaliella powder |
| 09/02/2010 | US20100221346 Method For Transfecting Cells Using A Magnetic Field |
| 09/02/2010 | US20100221345 Osteogenic biomaterial containing osteogenesis promoting substance and nanogel |
| 09/02/2010 | US20100221343 Compositions and methods of making brittle-matrix particles through blister pack freezing |
| 09/02/2010 | US20100221340 Method and compositions for treatment or prevention of inflammatory conditions |
| 09/02/2010 | US20100221339 Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts |
| 09/02/2010 | US20100221338 Coated Tablets Of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-Dihydro-5H-Pyrrolo[3,4-b]Pyrazine And Methods For Measuring Effectiveness Of Coating |
| 09/02/2010 | US20100221337 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and an h2 receptor antagonist |
| 09/02/2010 | US20100221336 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor |
| 09/02/2010 | US20100221335 Sustained-release preparation and method for producing the same |
| 09/02/2010 | US20100221334 Compositions including leukotriene antagonists and nsaids and methods of using the same |
| 09/02/2010 | US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 09/02/2010 | US20100221330 Buoyant formulations of betaine |
| 09/02/2010 | US20100221329 Formulations of guanylate cyclase c agonists and methods of use |
| 09/02/2010 | US20100221328 Sustained-release formulations |
| 09/02/2010 | US20100221327 Nanoparticulate azelnidipine formulations |
| 09/02/2010 | US20100221326 Pharmaceutical compositions for oral use for treating patients affected by obesity |
| 09/02/2010 | US20100221325 Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers |
| 09/02/2010 | US20100221324 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
| 09/02/2010 | US20100221323 Crystal Entecavir Formulation And The Preparation Method Thereof |
| 09/02/2010 | US20100221322 Abuse-Resistant Pharmaceutical Dosage Form |
| 09/02/2010 | US20100221321 Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses Or Conditions |
| 09/02/2010 | US20100221319 Compositions and Methods for Improved Skin Care |
| 09/02/2010 | US20100221318 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 09/02/2010 | US20100221317 Dynamin mediated diseases and associated methods and products |
| 09/02/2010 | US20100221316 Encapsulated Transfer Factor Compositions and Methods of Use |
| 09/02/2010 | US20100221315 Vesicular formulations containing organic acid prodrugs, process for their preparation |
| 09/02/2010 | US20100221313 Transdermal reservoir patch |
| 09/02/2010 | US20100221312 Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering |
| 09/02/2010 | US20100221311 Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering |
| 09/02/2010 | US20100221307 Antiviral agents, antiviral fibers and antiviral fiber structures |